1. Home
  2. YHC vs CDT Comparison

YHC vs CDT Comparison

Compare YHC & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc.

YHC

LQR House Inc.

N/A

Current Price

$1.80

Market Cap

2.2M

ML Signal

N/A

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

N/A

Current Price

$2.94

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YHC
CDT
Founded
2021
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.4M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
YHC
CDT
Price
$1.80
$2.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
164.2K
51.3K
Earning Date
04-15-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,120,622.00
N/A
Revenue This Year
$1,267.57
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
86.42
N/A
52 Week Low
$0.02
$0.30
52 Week High
$2.72
$11.00

Technical Indicators

Market Signals
Indicator
YHC
CDT
Relative Strength Index (RSI) 55.72 56.32
Support Level $0.71 $2.57
Resistance Level $2.20 $3.82
Average True Range (ATR) 0.20 0.35
MACD -0.04 -0.10
Stochastic Oscillator 44.26 30.70

Price Performance

Historical Comparison
YHC
CDT

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

Share on Social Networks: